Cambridge, MA, 28 mai — Insilico Medicine (« Insilico »), en collaboration avec un partenaire de recherche de Huadong Medicine Company, a annoncé aujourd'hui la découverte de nouveaux inhibiteurs de ...
MYC is a key integrator of growth-regulatory and oncogenic signalling pathways. MYC binds open chromatin and functions as a transcriptional activator and repressor of selected gene subsets. Detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results